People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Summary. Regeneron is financially strong, with steady cash flow, shareholder returns, and a healthy balance sheet, trading at a fair valuation. Their weight loss drug, trevogrumab could be a game ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China. The pharmaceutical company said ...

Weight loss drugs may cut cancer risk by 50% according to ‘transformational’ new study By . Carly Stern. Published May 12, 2025, 9:47 a.m. ET. Another win for the jab.

The initial Wall Street estimates for muscle-preserving therapies follow promising mid-stage results from experimental drugs developed by Regeneron and Scholar Rock ... can help patients maintain long ...

Combination Therapy Preserves Muscle Mass: Regeneron’s semaglutide plus trevogrumab combo significantly preserved lean muscle mass in patients with obesity, improving on the muscle loss typically seen ...

What’s the difference between Ozempic, Wegovy, other weight loss drugs? by Taylor Delandro - 05/07/25 7:07 AM ET. by Taylor Delandro - 05/07/25 7:07 AM ET.